Periprocedural acute haemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event

. 2024 Jun 03 ; 26 (6) : .

Jazyk angličtina Země Anglie, Velká Británie Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid38864730

Grantová podpora
LX22NPO5104 National Institute for Research of Metabolic and Cardiovascular Diseases
European Union, NextGenerationEU
00023001 project (Ministry of Health, Czech Republic) for development of research organization

AIMS: Patients with structural heart disease (SHD) undergoing catheter ablation (CA) for ventricular tachycardia (VT) are at considerable risk of periprocedural complications, including acute haemodynamic decompensation (AHD). The PAINESD score was proposed to predict the risk of AHD. The goal of this study was to validate the PAINESD score using the retrospective analysis of data from a large-volume heart centre. METHODS AND RESULTS: Patients who had their first radiofrequency CA for SHD-related VT between August 2006 and December 2020 were included in the study. Procedures were mainly performed under conscious sedation. Substrate mapping/ablation was performed primarily during spontaneous rhythm or right ventricular pacing. A purposely established institutional registry for complications of invasive procedures was used to collect all periprocedural complications that were subsequently adjudicated using the source medical records. Acute haemodynamic decompensation triggered by CA procedure was defined as intraprocedural or early post-procedural (<12 h) development of acute pulmonary oedema or refractory hypotension requiring urgent intervention. The study cohort consisted of 1124 patients (age, 63 ± 13 years; males, 87%; ischaemic cardiomyopathy, 67%; electrical storm, 25%; New York Heart Association Class, 2.0 ± 1.0; left ventricular ejection fraction, 34 ± 12%; diabetes mellitus, 31%; chronic obstructive pulmonary disease, 12%). Their PAINESD score was 11.4 ± 6.6 (median, 12; interquartile range, 6-17). Acute haemodynamic decompensation complicated the CA procedure in 13/1124 = 1.2% patients and was not predicted by PAINESD score with AHD rates of 0.3, 1.8, and 1.1% in subgroups by previously published PAINESD terciles (<9, 9-14, and >14). However, the PAINESD score strongly predicted mortality during the follow-up. CONCLUSION: Primarily substrate-based CA of SHD-related VT performed under conscious sedation is associated with a substantially lower rate of AHD than previously reported. The PAINESD score did not predict these events. The application of the PAINESD score to the selection of patients for pre-emptive mechanical circulatory support should be reconsidered.

Komentář v

doi: 10.1093/europace/euae144 PubMed

Zobrazit více v PubMed

Zeppenfeld  K, Tfelt-Hansen  J, de Riva  M, Winkel  BG, Behr  ER, Blom  NA, et al.  Esc guidelines for the management of V tachyarrhytmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Eur Heart J  2022;43:3997–4126. PubMed

Natale  A, Zeppenfeld  K, Della  BP, Liu  X, Sabbag  A, Santangeli  P, et al.  Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward. Europace  2023;25:euad225. PubMed PMC

Conti  S, Pala  S, Biagioli  V, Del Giorno  G, Zucchetti  M, Russo  E, et al.  Electrical storm: a clinical and electrophysiological overview. World J Cardiol  2015;7:555. PubMed PMC

Koželuhová  M, Peichl  P, Hlivák  P, Čihák  R, Wichterle  D, Vančura  V, et al.  Spektrum idiopatických komorových tachykardií ve specializovaném centru. Interv a akutní Kardiol  2009;8:228–232.

Bennett  RG, Turnbull  S, Sood  A, Aung  M, Duncan  E, Barman  P, et al.  Emergency out-of-hours catheter ablation for ventricular arrhythmia storm: a UK and Australian experience. Europace  2023;25:euad215. PubMed PMC

Gula  LJ, Doucette  S, Leong-Sit  P, Tang  ASL, Parkash  R, Sarrazin  JF, et al.  Quality of life with ablation or medical therapy for ventricular arrhythmias: a substudy of VANISH. J Cardiovasc Electrophysiol  2018;29:421–434. PubMed

Zeppenfeld  K, Wijnmaalen  AP, Ebert  M, Baldinger  SH, Berruezo  A, Catto  V, et al.  Clinical outcomes in patients with dilated cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol  2022;80:1045–1056. PubMed

Santangeli  P, Muser  D, Zado  ES, Magnani  S, Khetpal  S, Hutchinson  MD, et al.  Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythmia Electrophysiol  2015;8:68–75. PubMed

Muser  D, Castro  SA, Liang  JJ, Santangeli  P. Identifying risk and management of acute haemodynamic decompensation during catheter ablation of ventricular tachycardia. Arrhythmia Electrophysiol Rev  2018;7:282–287. PubMed PMC

Muser  D, Liang  JJ, Castro  SA, Hayashi  T, Enriquez  A, Troutman  GS, et al.  Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Hear Rhythm  2018;15:1500–1506. PubMed

Neuzner  J, Dietze  T, Paliege  R, Gradaus  R. Effectiveness of a percutaneous left ventricular assist device in preventing acute hemodynamic decompensation during catheter ablation of ventricular tachycardia in advanced heart failure patients: a retrospective single-center analysis. J Cardiovasc Electrophysiol  2019;30:2864–2868. PubMed

Mathuria  N, Wu  G, Rojas-Delgado  F, Shuraih  M, Razavi  M, Civitello  A, et al.  Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol  2017;48:27–34. PubMed

Kautzner  J, Čihák  R, Peichl  P, Vančura  V, Bytešník  J. Catheter ablation of ventricular tachycardia following myocardial infarction using three-dimensional electroanatomical mapping. Pacing Clin Electrophysiol  2003;26:342–347. PubMed

Kahle  AK, Jungen  C, Alken  FA, Scherschel  K, Willems  S, Pürerfellner  H, et al.  Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium. Europace  2022;24:538–551. PubMed

Hanaki  Y, Komatsu  Y, Nogami  A, Kowase  S, Kurosaki  K, Sekiguchi  Y, et al.  Combined endo- and epicardial pace-mapping to localize ventricular tachycardia isthmus in ischaemic and non-ischaemic cardiomyopathy. Europace  2022;24:587–597. PubMed

Yamashita  S, Sacher  F, Mahida  S, Berte  B, Lim  HS, Komatsu  Y, et al.  Image integration to guide catheter ablation in scar-related ventricular tachycardia. J Cardiovasc Electrophysiol  2016;27:699–708. PubMed

Yamashita  S, Sacher  F, Hooks  DA, Berte  B, Sellal  JM, Frontera  A, et al.  Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia. Hear Rhythm  2017;14:155–163. PubMed

Bunch  TJ, Weiss  JP, Crandall  BG, Day  JD, Dimarco  JP, Ferguson  JD, et al.  Image integration using intracardiac ultrasound and 3D reconstruction for scar mapping and ablation of ventricular tachycardia. J Cardiovasc Electrophysiol  2010;21:678–684. PubMed

Engert  F, Bahlke  F, Erhard  N, Krafft  H, Popa  M-A, Risse  E, et al.  VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients. Clin Res Cardiol  2023. doi:10.1007/s00392-023-02321-1 PubMed DOI PMC

Esposito  A, Palmisano  A, Antunes  S, Maccabelli  G, Colantoni  C, Rancoita  PMV, et al.  Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging  2016;9:822–832. PubMed

Siontis  KC, Kim  HM, Dabbagh  GS, Latchamsetty  R, Stojanovska  J, Jongnarangsin  K, et al.  Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy. Hear Rhythm  2017;14:1487–1493. PubMed

Komatsu  Y, Cochet  H, Jadidi  A, Sacher  F, Shah  A, Derval  N, et al.  Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythmia Electrophysiol  2013;6:342–350. PubMed

Kumar  S, Baldinger  SH, Romero  J, Fujii  A, Mahida  SN, Tedrow  UB, et al.  Substrate-based ablation versus ablation guided by activation and entrainment mapping for ventricular tachycardia: a systematic review and meta-analysis. J Cardiovasc Electrophysiol  2016;27:1437–1447. PubMed

Skhirtladze  K, Mora  B, Moritz  A, Birkenberg  B, Ankersmit  HJ, Dworschak  M. Impaired recovery of cardiac output and mean arterial pressure after successful defibrillation in patients with low left ventricular ejection fraction. Resuscitation  2010;81:1123–1127. PubMed

Eckardt  L, Doldi  F, Anwar  O, Gessler  N, Scherschel  K, Kahle  A-K, et al.  Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures CLINICAL RESEARCH. Europace  2023;26:1–12. PubMed PMC

Peichl  P, Wichterle  D, Pavlů  L, ČihÁk  R, Aldhoon  B, Kautzner  J. Complications of catheter ablation of ventricular tachycardia a single-center experience. Circ Arrhythmia Electrophysiol  2014;7:684–690. PubMed

Santangeli  P, Frankel  DS, Tung  R, Vaseghi  M, Sauer  WH, Tzou  WS, et al.  Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol  2017;69:2105–2115. PubMed

Martins  A, Antonio  PS, Pereira  SC, Brito  J, Silva  BV, Da Silva  PA, et al.  Is it possible to predict mortality and recurrence of VT after ablation? PAINESD risk score applicability vs new predictors. EP Eur  2022;24:40695.

Della  BP, Baratto  F, Tsiachris  D, Trevisi  N, Vergara  P, Bisceglia  C, et al.  Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation  2013;127:1359–1368. PubMed

Kusa  S, Miller  MA, Whang  W, Enomoto  Y, Panizo  JG, Iwasawa  J, et al.  Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhythmia Electrophysiol  2017;10:1–7. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...